Physician profile

Dennis C Ford

Pain Medicine (Anesthesiology) · Cleveland, TN

NPI 1063470045

$7,372.86

in general payments reported to CMS, 2019-2025

44 companies · $1,029 in 2025

The $1,029 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).

See the full distribution for Pain Medicine (Anesthesiology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,308.59

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $1,249.60 2021-2025
Collegium Pharmaceutical, INC. $1,226.64 2019-2025 Belbuca, Xtampza
Scilex Pharmaceuticals INC. $502.96 2019-2025 Ztlido
Novo Nordisk INC $432.41 2019-2025 Wegovy
Medtronic, INC. $389.84 2024-2025 Intellis Adaptivestim, Inceptiv
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $385.23 2019-2022
Pfizer INC. $367.38 2019-2025
Biodelivery Sciences International, INC. $335.03 2019-2021
Antares Pharma, INC. $281.83 2019-2025 Xyosted, Tlando, Nocdurna
Bausch Health US, LLC $252.52 2019-2020
Nevro Corp. $224.88 2023-2024 Senza
Allergan, INC. $191.17 2019-2021
Lilly USA, LLC $170.81 2019-2023 Emgality, Reyvow
Spr Therapeutics, INC $150.00 2024 Sprint Pns System
Amgen INC. $139.99 2024 Evenity, Prolia
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Grt US Holding, INC. $130.15 2022
Boston Scientific Corporation $81.37 2020-2025 Wavewriter Alpha Prime 16
Radius Health, INC. $79.03 2019-2020
Ibsa Pharma INC. $78.42 2021-2023 Tirosint, Licart
Saluda Medical Americas, INC. $56.34 2024-2025 Evoke
Ipsen Biopharmaceuticals, INC $43.98 2024-2025 Dysport
Horizon Therapeutics Plc $42.93 2019-2020
Lundbeck LLC $41.72 2023-2024 Vyepti
Averitas Pharma INC. $38.42 2023-2024 Qutenza
Zimmer Biomet Holdings, INC. $37.55 2019
Supernus Pharmaceuticals, INC. $31.75 2019-2021 Tlando, Xyosted
Pacira Therapeutics, INC. $31.01 2019
Tonix Medicines, INC. $30.62 2025 Tonmya
Daiichi Sankyo INC. $29.93 2019
Zyla Life Sciences, INC. $28.23 2019-2020
Merz Pharmaceuticals, LLC $25.61 2025 Xeomin
Shionogi INC $25.54 2019
Astrazeneca Pharmaceuticals LP $25.28 2019-2020
Redhill Biopharma INC. $24.86 2020-2021
Xeris Pharmaceuticals, INC. $23.37 2025 Gvoke Hypopen
Impel Pharmaceuticals INC. $22.53 2022
Biohaven Pharmaceuticals, INC. $22.37 2021
Takeda Pharmaceuticals U.S.A., INC. $22.14 2019
Halozyme INC $19.82 2023
Tolmar, INC. $19.12 2023
Hikma Pharmaceuticals USA $17.40 2021
Mdd US Operations, LLC $15.54 2022
Teva Pharmaceuticals USA, INC. $15.39 2020
Medtronic USA, INC. $12.15 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dennis C Ford

$7,372.86

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $1,029 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).

https://glasscript.com/doctor/184870/dennis-c-ford

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.